Nura Bio Completes $73.8M Series B Financing and Advances Pipeline of SARM1 Inhibitors
· nura bio, inc.
Source Summary
Nura Bio announced the completion of a Series B financing and the advancement of its two clinical-stage SARM1 inhibitor programs
Advertisement